Literature DB >> 23672965

Calcium isolation from large-volume human urine samples for 41Ca analysis by accelerator mass spectrometry.

James J Miller1, Susanta K Hui, George S Jackson, Sara P Clark, Jane Einstein, Connie M Weaver, Maryka H Bhattacharyya.   

Abstract

Calcium oxalate precipitation is the first step in preparation of biological samples for (41)Ca analysis by accelerator mass spectrometry. A simplified protocol for large-volume human urine samples was characterized, with statistically significant increases in ion current and decreases in interference. This large-volume assay minimizes cost and effort and maximizes time after (41)Ca administration during which human samples, collected over a lifetime, provide (41)Ca:Ca ratios that are significantly above background.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23672965      PMCID： PMC4089085          DOI： 10.1016/j.apradiso.2013.04.012

Source DB:  PubMed          Journal:  Appl Radiat Isot        ISSN： 0969-8043            Impact factor:   1.513


  12 in total

1.  Protocol for assessing bone health in humans by tracing long-lived 41Ca isotope in urine, serum, and saliva samples.

Authors:  Yumei Lin; Darren J Hillegonds; Erik R Gertz; Marta D Van Loan; John S Vogel
Journal:  Anal Biochem       Date:  2004-09-01       Impact factor: 3.365

Review 2.  Accelerator mass spectrometry for biomedical research.

Authors:  Karen Brown; Karen H Dingley; Kenneth W Turteltaub
Journal:  Methods Enzymol       Date:  2005       Impact factor: 1.600

3.  Use of accelerator mass spectrometry for studies in nutrition.

Authors:  G S Jackson; C Weaver; D Elmore
Journal:  Nutr Res Rev       Date:  2001-12       Impact factor: 7.800

4.  41Ca and accelerator mass spectrometry to monitor calcium metabolism in end stage renal disease patients.

Authors:  Robert L Fitzgerald; Darren J Hillegonds; Douglas W Burton; Terrance L Griffin; Scott Mullaney; John S Vogel; Leonard J Deftos; David A Herold
Journal:  Clin Chem       Date:  2005-09-01       Impact factor: 8.327

5.  Soy isoflavones do not affect bone resorption in postmenopausal women: a dose-response study using a novel approach with 41Ca.

Authors:  J M K Cheong; B R Martin; G S Jackson; D Elmore; G P McCabe; J R Nolan; S Barnes; M Peacock; C M Weaver
Journal:  J Clin Endocrinol Metab       Date:  2006-12-05       Impact factor: 5.958

6.  Labeling the human skeleton with 41Ca to assess changes in bone calcium metabolism.

Authors:  E Denk; D Hillegonds; J Vogel; A Synal; C Geppert; K Wendt; K Fattinger; C Hennessy; M Berglund; R F Hurrell; T Walczyk
Journal:  Anal Bioanal Chem       Date:  2006-10-11       Impact factor: 4.142

7.  Interpretation of 41Ca data using compartmental modeling in post-menopausal women.

Authors:  Wang-Hee Lee; Meryl E Wastney; George S Jackson; Berdine R Martin; Connie M Weaver
Journal:  Anal Bioanal Chem       Date:  2010-12-09       Impact factor: 4.142

8.  Evaluation of 41calcium as a new approach to assess changes in bone metabolism: effect of a bisphosphonate intervention in postmenopausal women with low bone mass.

Authors:  Eberhard Denk; Darren Hillegonds; Richard F Hurrell; John Vogel; Karin Fattinger; Hans J Häuselmann; Marius Kraenzlin; Thomas Walczyk
Journal:  J Bone Miner Res       Date:  2007-10       Impact factor: 6.741

9.  Cadmium intake and systemic exposure in postmenopausal women and age-matched men who smoke cigarettes.

Authors:  Andrea Ebert-McNeill; Sara P Clark; James J Miller; Paige Birdsall; Manisha Chandar; Lucia Wu; Elizabeth A Cerny; Patricia H Hall; Maribeth H Johnson; Carlos Isales; Norman Chutkan; Maryka H Bhattacharyya
Journal:  Toxicol Sci       Date:  2012-07-24       Impact factor: 4.849

10.  Antiresorptive effects of phytoestrogen supplements compared with estradiol or risedronate in postmenopausal women using (41)Ca methodology.

Authors:  C M Weaver; B R Martin; G S Jackson; G P McCabe; J R Nolan; L D McCabe; S Barnes; S Reinwald; M E Boris; M Peacock
Journal:  J Clin Endocrinol Metab       Date:  2009-07-07       Impact factor: 5.958
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.